View in EDS HTML Full Text PDF Full Text

Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study.

Saved in:
Bibliographic Details
Title: Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study.
Authors: Pearce SHS; 1Institute for Genetic Medicine, Newcastle University, and Newcastle Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom., Dayan C; 2Thyroid Research Group, School of Medicine, Cardiff University, Cardiff, United Kingdom., Wraith DC; 3Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham United Kingdom.; 6Institute of Metabolism and Systems Research, University of Birmingham, Birmingham United Kingdom.; 4Apitope Technology (Bristol) Ltd., Chepstow, United Kingdom., Barrell K; 4Apitope Technology (Bristol) Ltd., Chepstow, United Kingdom., Olive N; 4Apitope Technology (Bristol) Ltd., Chepstow, United Kingdom., Jansson L; 5Apitope International NV, Diepenbeek, Belgium., Walker-Smith T; 4Apitope Technology (Bristol) Ltd., Chepstow, United Kingdom., Carnegie C; 4Apitope Technology (Bristol) Ltd., Chepstow, United Kingdom., Martin KF; 4Apitope Technology (Bristol) Ltd., Chepstow, United Kingdom., Boelaert K; 6Institute of Metabolism and Systems Research, University of Birmingham, Birmingham United Kingdom., Gilbert J; 7Department of Endocrinology, King's College Hospital, London, United Kingdom., Higham CE; 8Department of Endocrinology, Christie Hospital NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom., Muller I; 2Thyroid Research Group, School of Medicine, Cardiff University, Cardiff, United Kingdom., Murray RD; 9Department of Endocrinology, St. James's University Hospital, Leeds, United Kingdom., Perros P; 10Endocrine Unit, Newcastle Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom., Razvi S; 11Institute for Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom., Vaidya B; 12Macleod Diabetes & Endocrine Centre, Royal Devon and Exeter Hospital, Exeter, United Kingdom., Wernig F; 13Department of Endocrinology, Imperial College, London, United Kingdom., Kahaly GJ; 14Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany.
Source: Thyroid : official journal of the American Thyroid Association [Thyroid] 2019 Jul; Vol. 29 (7), pp. 1003-1011. Date of Electronic Publication: 2019 Jun 13.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Mary Ann Liebert Publishers Country of Publication: United States NLM ID: 9104317 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-9077 (Electronic) Linking ISSN: 10507256 NLM ISO Abbreviation: Thyroid Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31194638
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pearce+SHS%22">Pearce SHS</searchLink>; 1Institute for Genetic Medicine, Newcastle University, and Newcastle Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dayan+C%22">Dayan C</searchLink>; 2Thyroid Research Group, School of Medicine, Cardiff University, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wraith+DC%22">Wraith DC</searchLink>; 3Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham United Kingdom.; 6Institute of Metabolism and Systems Research, University of Birmingham, Birmingham United Kingdom.; 4Apitope Technology (Bristol) Ltd., Chepstow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Barrell+K%22">Barrell K</searchLink>; 4Apitope Technology (Bristol) Ltd., Chepstow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Olive+N%22">Olive N</searchLink>; 4Apitope Technology (Bristol) Ltd., Chepstow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jansson+L%22">Jansson L</searchLink>; 5Apitope International NV, Diepenbeek, Belgium.<br /><searchLink fieldCode="AU" term="%22Walker-Smith+T%22">Walker-Smith T</searchLink>; 4Apitope Technology (Bristol) Ltd., Chepstow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Carnegie+C%22">Carnegie C</searchLink>; 4Apitope Technology (Bristol) Ltd., Chepstow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Martin+KF%22">Martin KF</searchLink>; 4Apitope Technology (Bristol) Ltd., Chepstow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Boelaert+K%22">Boelaert K</searchLink>; 6Institute of Metabolism and Systems Research, University of Birmingham, Birmingham United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gilbert+J%22">Gilbert J</searchLink>; 7Department of Endocrinology, King's College Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Higham+CE%22">Higham CE</searchLink>; 8Department of Endocrinology, Christie Hospital NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Muller+I%22">Muller I</searchLink>; 2Thyroid Research Group, School of Medicine, Cardiff University, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Murray+RD%22">Murray RD</searchLink>; 9Department of Endocrinology, St. James's University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Perros+P%22">Perros P</searchLink>; 10Endocrine Unit, Newcastle Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Razvi+S%22">Razvi S</searchLink>; 11Institute for Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Vaidya+B%22">Vaidya B</searchLink>; 12Macleod Diabetes & Endocrine Centre, Royal Devon and Exeter Hospital, Exeter, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wernig+F%22">Wernig F</searchLink>; 13Department of Endocrinology, Imperial College, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kahaly+GJ%22">Kahaly GJ</searchLink>; 14Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229104317%22">Thyroid : official journal of the American Thyroid Association</searchLink> [Thyroid] 2019 Jul; Vol. 29 (7), pp. 1003-1011. <i>Date of Electronic Publication: </i>2019 Jun 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mary+Ann+Liebert+Publishers%22">Mary Ann Liebert Publishers </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9104317 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-9077 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210507256%22">10507256 </searchLink><i>NLM ISO Abbreviation: </i>Thyroid <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31194638
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1089/thy.2019.0036
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1003
    Titles:
      – TitleFull: Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pearce SHS
      – PersonEntity:
          Name:
            NameFull: Dayan C
      – PersonEntity:
          Name:
            NameFull: Wraith DC
      – PersonEntity:
          Name:
            NameFull: Barrell K
      – PersonEntity:
          Name:
            NameFull: Olive N
      – PersonEntity:
          Name:
            NameFull: Jansson L
      – PersonEntity:
          Name:
            NameFull: Walker-Smith T
      – PersonEntity:
          Name:
            NameFull: Carnegie C
      – PersonEntity:
          Name:
            NameFull: Martin KF
      – PersonEntity:
          Name:
            NameFull: Boelaert K
      – PersonEntity:
          Name:
            NameFull: Gilbert J
      – PersonEntity:
          Name:
            NameFull: Higham CE
      – PersonEntity:
          Name:
            NameFull: Muller I
      – PersonEntity:
          Name:
            NameFull: Murray RD
      – PersonEntity:
          Name:
            NameFull: Perros P
      – PersonEntity:
          Name:
            NameFull: Razvi S
      – PersonEntity:
          Name:
            NameFull: Vaidya B
      – PersonEntity:
          Name:
            NameFull: Wernig F
      – PersonEntity:
          Name:
            NameFull: Kahaly GJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2019 Jul
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1557-9077
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Thyroid : official journal of the American Thyroid Association
              Type: main
ResultId 1